Aptose Biosciences Stock One Year Return
APS Stock | CAD 0.27 0.07 20.59% |
Aptose Biosciences fundamentals help investors to digest information that contributes to Aptose Biosciences' financial success or failures. It also enables traders to predict the movement of Aptose Stock. The fundamental analysis module provides a way to measure Aptose Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aptose Biosciences stock.
Aptose | One Year Return |
Aptose Biosciences Company One Year Return Analysis
Aptose Biosciences' One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
More About One Year Return | All Equity Analysis
One Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Aptose One Year Return Driver Correlations
Understanding the fundamental principles of building solid financial models for Aptose Biosciences is extremely important. It helps to project a fair market value of Aptose Stock properly, considering its historical fundamentals such as One Year Return. Since Aptose Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aptose Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aptose Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.
Competition |
Aptose Return On Tangible Assets
Return On Tangible Assets |
|
Based on the recorded statements, Aptose Biosciences has an One Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Canada stocks average (which is currently at 0.0).
Aptose Biosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Aptose Biosciences from analyzing Aptose Biosciences' financial statements. These drivers represent accounts that assess Aptose Biosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Aptose Biosciences' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 19.0M | 23.9M | 8.0M | 3.6M | 3.2M | 4.6M | |
Enterprise Value | (59.3M) | (92.4M) | (30.5M) | (32.1M) | (36.9M) | (35.1M) |
Aptose Fundamentals
Return On Equity | -6.94 | ||||
Return On Asset | -1.36 | ||||
Current Valuation | (5.23 M) | ||||
Shares Outstanding | 19.52 M | ||||
Shares Owned By Insiders | 15.87 % | ||||
Shares Owned By Institutions | 16.68 % | ||||
Number Of Shares Shorted | 2.36 K | ||||
Price To Earning | (1.85) X | ||||
Price To Book | 68.22 X | ||||
EBITDA | (52.27 M) | ||||
Net Income | (51.21 M) | ||||
Cash And Equivalents | 36.37 M | ||||
Cash Per Share | 0.64 X | ||||
Total Debt | 1.01 M | ||||
Debt To Equity | 5.00 % | ||||
Current Ratio | 11.27 X | ||||
Book Value Per Share | (0.36) X | ||||
Cash Flow From Operations | (44.59 M) | ||||
Short Ratio | 0.48 X | ||||
Earnings Per Share | (4.08) X | ||||
Target Price | 31.02 | ||||
Number Of Employees | 35 | ||||
Beta | 1.36 | ||||
Market Capitalization | 5.27 M | ||||
Total Asset | 12.99 M | ||||
Retained Earnings | (515.54 M) | ||||
Working Capital | (3.38 M) | ||||
Net Asset | 12.99 M |
About Aptose Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aptose Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptose Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptose Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aptose Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Aptose Stock
0.47 | WMT | Walmart Inc CDR | PairCorr |
0.36 | TSLA | Tesla Inc CDR | PairCorr |
0.31 | BRK | Berkshire Hathaway CDR | PairCorr |
The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.